 SEATTLE, May 02, 2022 GLOBE NEWSWIRE -- Chinook Therapeutics, Inc. NASDAQ: KDNY, a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced upcoming data presentations at the 59th ERA Congress from May 19 22, 2022, both virtual and live in Paris, France. Two abstracts will be delivered as free communications 15 minute live oral presentations and three abstracts will be delivered as mini-oral presentations 5 minute pre-recorded presentations. 